重要新發現
近日，強生全視給眼視光觀察發來新聞稿，題目是《強生全視在ARVO年會上發表目前為止最大規模的兒童近視研究之一的新發現：近視篩查和教育在亞太地區取得重大進展》，以下是中英文全文。
Johnson & Johnson Vision Presents New Myopia Progression
Findings from One of the Largest Studies with Children at ARVO Annual Meeting
強生全視在ARVO年會上發表目前為止最大規模的兒童近視研究之一的新發現
Significant Progress Made in Myopia Screening and Education in Asia Pacific
近視篩查和教育在亞太地區取得重大進展
· Study Recommends Annual Eye Exams Globally for Patients with Myopia
· Nearly 35,000 Children in Asia Pacific Receive Eye Exams with Myopia Screening
· 研究建議全球近視患者每年進行一次眼部檢查
· 亞太地區近35000名兒童接受近視篩查
Jacksonville, Fla, and Santa Ana, Calif., June 12, 2020 -- Johnson & Johnson Vision^, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies^^, today announced new clinical research on Myopia progression in children and detailed significant child Myopia screening and education progress in the Asia Pacific region. The clinical research and public health programs are part of the comprehensive Myopia research collaboration with the Singapore Eye Research Institute (SERI) and Singapore National Eye Centre (SNEC) launched in April 2019.
（2020年6月12日 美國佛羅裡達州傑克遜維爾和加利福尼亞州聖安娜）作為全球眼健康領導者之一，強生全視今天發布了一項新的關於兒童近視進展的臨床研究，並詳述了亞太地區兒童近視篩查和教育的重大進展。該臨床研究和公共衛生項目是與新加坡眼科研究所(SERI)和新加坡國立眼科中心(SNEC)於2019年4月啟動的全面近視研究合作的一部分。（點擊此處查看相關文章：新加坡全國眼科中心、眼科研究所與強生合作，旨在消除全球普遍近視現象）
「Current estimates show that by 2050 half of the world’s population is expected to be myopic, with a disproportionate impact on our children,」 said Xiao-Yu Song, MD, PhD, Global Head of Research and Development, Johnson & Johnson Vision Care, Inc. 「Through close collaborations with SERI, SNEC and other aligned public health groups, we are helping to address this crisis by building a better understanding of the science and biology behind Myopia and developing comprehensive programs to address and treat the disease.」
「根據預計，到2050年世界上有一半的人口將會發生近視，對我們的孩子造成較大程度的影響，」強生視力健公司全球研發負責人宋曉宇博士說，「通過與SERI、SNEC和其他公共衛生組織的密切合作，我們正在通過更好地建立對於近視背後的科學和生物學的理解，並制定全面的方案防控和治療這一疾病，來解決這個危機。」
This week researchers for the collaboration presented some of its first clinical research findings at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting. The collaboration’s five studies at ARVO focus on new techniques and practices to better predict Myopia progression and vision impairment, significant challenges for eye care professionals when so much of Myopia disease progression is still to be understood.
本周，項目研究人員在視覺和眼科研究協會（ARVO）年會上發表了一些首次臨床研究的發現。此次發表在ARVO上的五項研究集中在新的技術和實踐上，以更好地預測近視進展和視力損害，以及許多近視疾病進展尚不清楚給眼視光專業人員帶來的重大挑戰。
The research team presented new findings on Myopia progression from one of the largest clinical research studies with children. In the study of 674 myopic children aged seven to 10-years old over two-years, the authors found that a child’s prior year Myopia progression correlates with immediate subsequent year progression. That is, the investigators found that children with slow Myopia progression during the first year generally had slow progression in year two, while children with fast Myopia progression in year one generally had fast progression in year two.
作為目前為止最大規模的兒童近視研究之一，該研究小組發表了兒童近視發生發展方面的一些新發現。對674名7-10歲的近視兒童進行了超過兩年的研究發現，兒童的前一年近視進展與後一年的進展密切相關。也就是說，研究者發現，第一年近視進展緩慢的兒童在第二年通常進展緩慢，而第一年近視進展迅速的兒童在第二年通常進展迅速。
However, the authors report that year-over-year progression as a single factor does not fully predict long-term Myopia progression and that a child’s age and parental Myopia are important additional variables to consider in choosing whether to treat a child’s progression.
然而，研究者報告也提到，每年近視的增長程度作為一個單一因素並不能完全預測長期近視的進展，而孩子的年齡和父母近視是選擇兒童近視進展治療的重要附加變量。
「Globally, for parents of children with Myopia, and eye care professionals, an important takeaway is the need for myopic patients to receive regular annual check-ups,」 said study lead author Noel Brennan, PhD, Global Lead, Myopia Control, Johnson & Johnson Vision. 「While Myopia progression rates will naturally be followed from year-to-year, it is also important that eye care professionals consider age of Myopia onset and parental Myopia.」
「全球範圍內，對於近視兒童的父母和眼視光專業人員來說，一個重要的結論是近視患者需要每年進行定期檢查，」 該研究的主要作者、強生全視近視防控全球負責人Noel Brennan博士說：「雖然近視進展率會自然地逐年獲得跟進，但對於眼視光專業人員來說，考慮近視發病年齡和父母近視也很重要。」
The author presentation andstudy, Annual Myopia Progression and Subsequent Year Progression in Singaporean Children, was published today onARVOLearn as part of ARVO’s virtual congress.
作為ARVO線上大會的一部分，作者的報告和研究《新加坡兒童的年度近視進展及隨後的年度進展》今天在ARVOLearn上發表。
MYOPIA Screening and Education Program Progress in asia pacific
亞太地區近視篩查及教育計劃進展情況
Since the formal launch of the collaboration just over a year ago, Johnson & Johnson Vision, Johnson & Johnson Global Community Impact, SERI and SNEC have also been working to advance critical Myopia screening and education programs in the Asia Pacific region where current Myopia prevalence rates among young people are high. In Singapore, for example, one in two children develop Myopia by the age of 12, and 75 percent of teenagers are myopic and rely on glasses. Left unchecked, in some patients, Myopia can lead to blindness or other eye health conditions that can severely impact vision and overall well-being.
自項目合作正式啟動一年多以來，強生全視、強生全球社區影響部門、SERI以及SNEC始終致力於在青少年近視患病率高的亞太地區推進高度近視的篩查和教育項目。例如，在新加坡，每兩個孩子中就有一個在12歲之前患上近視，75%的青少年患有近視並依賴眼鏡。如果不加以控制，對一些患者來說，近視可能導致失明，或其他嚴重影響視力和整體健康的眼部健康問題。
「Tackling the Myopia epidemic globally requires a comprehensive approach that includes critical education and screening campaigns,」 said Dr. Song. 「We are very pleased by the progress of the public health programs in Asia being supported by the collaboration, and that young children are receiving comprehensive eye exams and necessary referrals when diagnosed with Myopia. We look forward to continued progress as we learn to manage these initiatives through the COVID-19 pandemic.」
「應對全球近視流行需要全面的方法，包括關鍵的教育和篩查活動。」宋博士說，「我們很高興地看到，亞洲的公共衛生項目在多方力量的合作與支持下取得了進展，而且當兒童被診斷為近視時，他們正在接受全面的眼科檢查和必要的轉診。我們期待在學習如何通過新冠疫情管理這些舉措的過程中繼續取得進展。」
Working through the Fred Hollows Foundation, and China’s Yunnan Provincial Health Commission and Provincial Education Department, the collaboration launched its three-and-a-half-year Child Eye-Health Program in China’s Yunnan Province in August 2019. The program trains ophthalmologists, refractionists, community health workers and teachers in screening techniques and supports student screening programs. In the second half of 2019, the collaboration has already supported the screening of nearly 30,000 primary school students in Yunnan Province, and provided eye health and myopia prevention knowledge to almost 20,000 students.
通過與弗雷德霍洛基金會（Fred Hollows Foundation）、中國雲南省衛生健康委員會和省教育廳的合作，我們於2019年8月在中國雲南省啟動了為期三年半的兒童眼健康項目。該項目旨在培訓眼科醫生、驗光師、社區衛生工作者和教師的篩查技術，並對於學生篩查項目給予支持。2019年下半年，該合作已支持雲南省近3萬名小學生的篩查，並為近2萬名學生提供了眼健康和近視預防知識。
The collaboration has also become a strategic partner with the the Ministry of Education’s Research Center for Prevention, Control and Diagnosis of Myopia to support the improvement of Myopia public awareness and the development of Myopia awarnesss education tools. In addition, the collaboration is working with the Beijing Preventative Medicine Association and Beijing CDC on a Myopia school screening program that is seeking to examine 4,000 students from September 2019 to the end of 2020.
該合作項目還與中國教育部近視防控與診治工程研究中心結成戰略合作夥伴，支持提高近視公眾意識和開發近視防控教育工具。此外，該合作項目正與北京市預防醫學會和北京市疾控中心合作開展近視學校篩查項目，於2019年9月至2020年底對4000名學生進行檢查。
來源 | 強生全視
值班編輯 | 李靜 總編 | 張玲